Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner. It achieves this by combining over two decades of healthcare domain expertise and fit-for purpose technology.

Indegene major competitors are Syngene Internation., Jubilant Pharmova, Caplin Point Lab, Blue Jet Healthcare, Sanofi India, Sai Life Sciences, Alivus Life Sciences.
Market Cap of Indegene is ₹13,850 Crs.
While the median market cap of its peers are ₹14,720 Crs.

Indegene seems to be less financially stable compared to its competitors.
Altman Z score of Indegene is 10.81 and is ranked 4 out of its 8 competitors.